17139 Comparative cost-effectiveness for tildrakizumab and other targeted therapies for the treatment of moderate to severe plaque psoriasis in the United States

2020 ◽  
Vol 83 (6) ◽  
pp. AB80
Author(s):  
Xiaoying Jia ◽  
Alan Mendelsohn ◽  
Justin Carrico ◽  
Thor-Henrik Brodtkorb ◽  
Yang Zhao ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Plaque Psoriasis ◽  
Targeted Therapies ◽  
The United States ◽  
Severe Plaque Psoriasis ◽  
Comparative Cost

scholarly journals Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States

2015 ◽  
Vol 73 (4) ◽  
pp. 585-593.e3 ◽  
Author(s):  
Caroline P. Schaefer ◽  
Joseph C. Cappelleri ◽  
Rebecca Cheng ◽  
Jason C. Cole ◽  
Scott Guenthner ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
Resource Use ◽  
Plaque Psoriasis ◽  
The United States ◽  
Health Care Resource ◽  
Severe Plaque Psoriasis ◽  
Health Care Resource Use

Cost-Effectiveness of Inhaled Nitric Oxide in the Treatment of Neonatal Respiratory Failure in the United States

PEDIATRICS ◽  
2003 ◽  
Vol 112 (6) ◽  
pp. 1351-1360 ◽  
Author(s):  
D. C. Angus ◽  
G. Clermont ◽  
R. S. Watson ◽  
W. T. Linde-Zwirble ◽  
R. H. Clark ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
United States ◽  
Cost Effectiveness ◽  
Respiratory Failure ◽  
The United States ◽  
Inhaled Nitric Oxide
Sign in / Sign up

Export Citation Format

Share Document